Literature DB >> 12163232

Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis.

Lawrence A Frohman1, Rhonda D Kineman.   

Abstract

Growth hormone-releasing hormone (GHRH) is essential for expansion of the somatotrope lineage during pituitary development, and excessive GHRH secretion and/or action results in unregulated somatotrope proliferation and neoplastic transformation. Our understanding of the molecular and morphological bases for these effects from both animal and clinical studies has greatly increased during the past decade. However, many features of the cellular pathways remain to be defined, including the interaction of other genes in the multistep process of somatotrope tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163232     DOI: 10.1016/s1043-2760(02)00613-6

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  19 in total

1.  Loss of Gq/11 family G proteins in the nervous system causes pituitary somatotroph hypoplasia and dwarfism in mice.

Authors:  N Wettschureck; A Moers; B Wallenwein; A F Parlow; C Maser-Gluth; S Offermanns
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

2.  Foxo1 Is Required for Normal Somatotrope Differentiation.

Authors:  Jyoti Kapali; Brock E Kabat; Kelly L Schmidt; Caitlin E Stallings; Mason Tippy; Deborah O Jung; Brian S Edwards; Leah B Nantie; Lori T Raeztman; Amy M Navratil; Buffy S Ellsworth
Journal:  Endocrinology       Date:  2016-09-15       Impact factor: 4.736

3.  Inhibition of tumor growth by agonists of growth hormone-releasing hormone.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-07       Impact factor: 11.205

4.  Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.

Authors:  Zoltan Rekasi; Tamas Czompoly; Andrew V Schally; Ferenc Boldizsar; Jozsef L Varga; Marta Zarandi; Timea Berki; Reka A Horvath; Peter Nemeth
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

5.  Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor.

Authors:  F Rodríguez-Pacheco; C Gutierrez-Repiso; S García-Serrano; A Ho-Plagaro; J M Gómez-Zumaquero; S Valdes; M Gonzalo; J Rivas-Becerra; C Montiel-Casado; G Rojo-Martínez; E García-Escobar; E García-Fuentes
Journal:  Int J Obes (Lond)       Date:  2017-06-19       Impact factor: 5.095

6.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.

Authors:  Victoria Florea; Sonia S Majid; Rosemeire M Kanashiro-Takeuchi; Ren-Zhi Cai; Norman L Block; Andrew V Schally; Joshua M Hare; Claudia O Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

7.  Pituitary miRNAs target GHRHR splice variants to regulate GH synthesis by mediating different intracellular signalling pathways.

Authors:  Yunyun Cheng; Ting Chen; Jie Song; Zhaohui Teng; Chunli Wang; Siyao Wang; Guanhong Lu; Tianqi Feng; Qien Qi; Qianyun Xi; Songcai Liu; Linlin Hao; Yongliang Zhang
Journal:  RNA Biol       Date:  2020-06-19       Impact factor: 4.652

8.  Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation.

Authors:  Yong Jie Qin; Sun On Chan; Kelvin Kam Lung Chong; Benjamin Fuk Loi Li; Tsz Kin Ng; Yolanda Wong Ying Yip; Haoyu Chen; Mingzhi Zhang; Norman L Block; Herman S Cheung; Andrew V Schally; Chi Pui Pang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

9.  Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; Andrew V Schally; Gabor Halmos; Jozsef L Varga; Helen Koutselini; Anastasios Kalofoutis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

Review 10.  Magnetic resonance imaging of the hypothalamus-pituitary unit in childrensuspected of hypopituitarism: who, how and when toinvestigate.

Authors:  M Maghnie; S Ghirardello; E Genovese
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.